23Apr/13

Justice Verma, the face of judicial activism, dies of multiple organ failure – Indian Express


Indian Express

Justice Verma, the face of judicial activism, dies of multiple organ failure
Indian Express
Doctors at Medanta Medicity said he died of multiple organ failure. “He was brought to us with excessive gastro-intestinal bleeding on Friday, and we found that his liver had started failing. We admitted him in the ICU and put him on intensive
Justice JS Verma dies due to multiple organ failureHindustan Times
Justice Verma passes away due to liver failureIndia.Com Health
Anti-rape law panel chief Verma dead – Khaleej TimesKhaleej Times
Kashmir Times –Gulf Times
all 58 news articles »
23Apr/13

Federal Circuit finds prosecution history disclaimer in enablement arguments – Lexology (registration)

Federal Circuit finds prosecution history disclaimer in enablement arguments
Lexology (registration)
The specification describes Biogen’s product Rituxan® (rituximab) as a preferred embodiment. Rituximab binds to a large loop of the CD20 protein that is exposed on the cell surface. This loop constitutes the particular “epitope” recognized by the

23Apr/13

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline … – Fort Mills Times

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline
Fort Mills Times
Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Congestive Heart Failure

and more »

23Apr/13

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline … – Wall Street Journal

Research and Markets: Congestive Heart Failure (Heart Failure) – Pipeline
Wall Street Journal
Research and Markets has announced the addition of the “Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2013″ report to their offering. Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) – Pipeline Review, H1 2013

and more »